Tagged with

LG Life Sciences LG Life Sciences seems quite unique among the rest of pharmaceutical companies in Korea which tend to be family owned. How has this set LGLS apart in terms of its development and strategy in the industry? Traditionally, companies in Korea have focused on generic drugs and in-licensing new medicines, so…

Toscana Life Sciences Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the regional and local level whereas it is not the case in most other countries where the national government is strongly…

Lee&Ko Could you introduce Lee & Ko to our readers? Established in 1977, Lee & Ko is the largest and the leading law firm in Korea, consisting of 310 professionals, including 246 Korean and foreign attorneys, 56 patent/trademark attorneys, and accounts, and about 500 staff members, with expertise and experience in…

Institut Pasteur How would you define the Institut Pasteur’s relationship with the pharmaceutical industry and how it has evolved in recent years? Since its foundation 120 years ago, the Institut Pasteur has had a close relationship with the pharmaceutical industry. I would even say this relationship is in the institute’s own genes.…

Bristol-Myers Squibb The pharmaceutical industry in Asia is undergoing a period of specialization with R&D booming in places like Australia, Singapore and South Korea and manufacturing in places like China, India and now Vietnam – how does Indonesia fit into the overall picture? Indonesia has a number of very strong fundamental, macroeconomic…

Nordic Pharma France Nordic Pharma has been established in the French market since 2002 as one of its first steps towards internationalization. What have been the main milestones and achievements of Nordic in the French market since then? Since our establishment on the French market in 2002, Nordic Pharma has had a number…

Celgene France In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head of Celgene France’s operations, what were the main milestones of the company since its establishment in the French market in…

Octapharma was founded in 1983 and entered decisively in the French market in 1999, when it acquired a plasma facility in Lingolsheim, Alsace. Since then, what have been the main milestones of the company, especially since you took the reins of the local operations five years ago? Until 2005 Octapharma…

Colombia today is not the Colombia of mainstream Hollywood. Once a country ravaged by domestic insecurity whose images of terror were exported to the rest of the world, the journey of Colombia over the past decade to its current economic, political, and social stability are a role model for Latin…

Depolabo As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the French market. As the one responsible for these changes, what was your strategy to further consolidate Depolabo’s leadership in France?…

This year Menarini will launch several new products in France to add to its current portfolio. Apart from this, can you tell us about activities and position in France? Our sales have reached 131 million € in 2009 . Our ranking in France is now at the 34th level versus…

Chiesi France The basis of the pharmaceutical business model is changing. Take sales forces for instance, what will be the composition and daily routine? How much mixed media will it require? Currently, there is a schizophrenic state in to the market in between biotechnologies and generics. This is a clear case of…